Search Results
May 27, 2026, 09:00 ET SHAREHOLDER ALERT: Levi & Korsinsky Issues Amended Summary Notice of Class Action Settlement
Rules 23(a), 23(b)(i), and 23(b)(ii), (ii) determine whether Plaintiffs and Plaintiffs' counsel have adequately represented the interests of the Class; (iii) determine whether the proposed Settlement, as set forth in the Stipulation, should be approved by the Court as fair, reasonable, adequate, and in the
More news about: Levi & Korsinsky, LLP
May 27, 2026, 09:00 ET Zoomcar Holdings, Inc. Announces Completion of Key Milestone in Financial Restructuring
and customer acquisition, and supporting the Company's previously stated objective of pursuing an uplisting to a U.S. national securities exchange; (iii) the Company's ability to pursue and consummate an uplisting to a U.S. national securities exchange, the timing thereof, and the Company's ability to
More news about: Zoomcar
May 27, 2026, 08:31 ET Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight
one-time treatment for wet AMD, diabetic retinopathy, and other chronic retinal disorders. RGX-314 is presently under investigation in Phase III and Phase II/III clinical studies for wet AMD, with global regulatory submissions anticipated in the first half of 2026.Ocugenix's OGX-110 is an
More news about: DelveInsight Business Research, LLP
May 27, 2026, 08:11 ET Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq: RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing for Space and Defense Applications
opportunities: (i) AI chip and memory hardware engineered for orbital and high-radiation environments; (ii) nano-launch and nanosatellite enablement; and (iii) defense and national security applications where radiation tolerance, energy efficiency, and on-device intelligence intersect. The Company believes
More news about: Hoth Therapeutics, Inc.
May 27, 2026, 08:00 ET Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting
disease-free survival as determined by investigator, and the primary completion date is estimated to be in 2030. Nuvation Bio is also sponsoring TRUST-III (
More news about: Nuvation Bio Inc.
May 27, 2026, 07:30 ET Einride Teams up with TÜV SÜD for Independent Verification of First Autonomous Safety Management Governance Framework
[email protected] Merger Corp. III Eric Rosenfeld Chief SPAC Officer Legato Merger Corp. III [email protected] This
More news about: Einride
May 27, 2026, 07:27 ET Einride Teams up with TÜV SÜD for Independent Verification of First Autonomous Safety Management Governance Framework
[email protected] Merger Corp. III Eric Rosenfeld Chief SPAC Officer Legato Merger Corp. III [email protected] This
More news about: Einride
May 27, 2026, 07:27 ET Natural Grocers® Opens Its Doors in Lake Geneva, Wisconsin, With a Grand Opening Celebration on June 10, 2026
Grocers' Lake Geneva, WI location. No rain checks. Limit one per customer, 18 years or older. Valid 6/10/2026 only. Void where prohibited by law.[iii] Prize wheel available at Natural Grocers' Lake Geneva, WI location. No purchase necessary. Quantity limited to stock on hand; no rain checks. Valid
More news about: Natural Grocers by Vitamin Cottage, Inc.
May 27, 2026, 06:30 ET ORVANA PROVIDES TAGUAS DRILLING UPDATE: FULL ASSAY RESULTS FROM TADD-278; SECOND HOLE RESULTS PENDING
but is not limited to statements regarding: (i) the next steps of the Taguas exploration campaign; (ii) interpretation of a porphyry-related system; (iii) plans for the next drilling campaign; (iv) potential for copper-gold mineralization; and (v) geochronological study plans. There is no assurance that
More news about: Orvana Minerals Corp.
May 27, 2026, 05:38 ET Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List
mainland.The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago, United States from 29 May to 2 June. Data from a Phase III study of luvometinib tablets (FUMAINING) in adult patients with symptomatic, inoperable PN associated with NF1 has been successfully selected for a Rapid
More news about: Fosun
May 27, 2026, 05:14 ET WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
operations, and more efficient manufacturing. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.WuXi Biologics regards
More news about: WuXi Biologics
May 27, 2026, 04:43 ET Foresee Pharmaceuticals Announces Completion of Casppian Phase 3 Study with Last Patient Last Visit and Confirms Topline Results: 94% of Patients Achieve LH Suppression with 6-Month Dosing Interval of Leuprolide Mesylate, also the acceptance of Casppian Study for Presentation at Endocrine Society, ENDO 2026 Medical Conference, as a Potential New Six-Month Treatment Option for Central Precocious Puberty
conference in pediatric endocrinology. In addition, the Phase III Casppian Study for FP-001 was accepted for Presentation at the Endocrine Society, ENDO 2026.The abstract, titled: An Open-label, Single Arm, Multicenter, Phase III Study on the Efficacy, Safety, and Pharmacokinetics of FP-001
More news about: Foresee Pharmaceuticals Co., Ltd.
May 26, 2026, 19:50 ET SILVERCORP REPORTS ADJUSTED NET INCOME OF $151 MILLION, $0.69 PER SHARE, AND CASH FLOW FROM OPERATING ACTIVITIES OF $310.6 MILLION FOR FISCAL 2026
Total capitalized expenditures amounted to $6.0 million, primarily for sustaining activities, as compared to $6.7 million in Fiscal 2025.iii) El Domo ProjectCapital expenditures for El Domo totaled $46.4 million, compared to $7.5 million in Fiscal 2025. Mine development activities
More news about: Silvercorp Metals Inc.
May 26, 2026, 17:01 ET Sun Life Receives Regulatory Approval of Normal Course Issuer Bid Renewal
including under the automatic repurchase plan), (ii) that are predictive in nature or that depend upon or refer to future events or conditions, and (iii) that include words such as "intends", "expects", "will" and similar expressions. The forward-looking statements made in this news release are stated
More news about: Sun Life Financial Inc. - Financial News
May 26, 2026, 17:01 ET Sun Life Receives Regulatory Approval of Normal Course Issuer Bid Renewal
including under the automatic repurchase plan), (ii) that are predictive in nature or that depend upon or refer to future events or conditions, and (iii) that include words such as "intends", "expects", "will" and similar expressions. The forward-looking statements made in this news release are stated
More news about: Sun Life Financial Inc. - Financial News
May 26, 2026, 17:00 ET SOLAI Limited Announces Unaudited Financial Results for the Three Months Ended March 31, 2026
Ethiopia data center due to the completion of business deployment in Ethiopia; (ii) an increase of US$0.8 million in Ohio data center, which was offset by (iii) the decrease of US$2.8 million self-mining business revenue as a result of falling cryptocurrency prices and reduced mining operating hours.
More news about: SOLAI Limited
May 26, 2026, 16:15 ET Suncrete Announces Dual Listing on Nasdaq Texas
communities. We look forward to continuing to invest in and serve the residents, customers, and companies that proudly call Texas home."Ned N. Fleming, III, the Company's Executive Chairman, stated, "This dual listing reflects our deep, long-term commitment to Texas and reinforces a core competence at Suncrete
More news about: Suncrete, Inc.
May 26, 2026, 16:05 ET Hitek Announces 1-for-3 Reverse Split
(i) 20,000,000 Class A Ordinary Shares, par value US$0.015 per share, (ii) 150,000,000 Class B ordinary shares, par value US$0.0001 per share, and (iii) 10,000,000 preference shares, par value US$0.0001 per share. Prior to the Reverse Split, there were 2,324,420 Class A Ordinary Shares and 8,192,000
More news about: HITEK GLOBAL INC
May 26, 2026, 13:04 ET Borr Drilling Limited - Announces Any and All Cash Tender Offer for Notes Due 2028 and Partial Cash Tender Offer for Notes Due 2030 and Consents Solicitation for Proposed Amendments to the Indenture
the 2028 Notes, (ii) remove certain rights of holders of 2028 Notes upon the occurrence of certain Events of Default (as defined in the Indenture), (iii) align and conform certain covenants, definitions and other terms in the Indenture with those that will be contained in the indenture that will govern
More news about: Borr Drilling Limited
May 26, 2026, 12:33 ET Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo's business, (iii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, including
More news about: Inductive Bio, Inc.
May 26, 2026, 12:20 ET BrightNight Announces Financial Close for Frontier, a 120 MW Solar Project Delivering Clean Power to Kentucky
we're proud to serve, and powering that growth, we're proud to operate one of the most reliable generation fleets in the nation," said John R. Crockett III, President for LG&E and KU. "Our partnership with BrightNight on the Frontier project is an important step in advancing additional renewable energy
More news about: BrightNight
May 26, 2026, 11:58 ET New Med to Manage Tourette Syndrome Shows Promise in Phase III Clinical Trial
May 26, 2026, in JAMA Neurology describing the results of a recently completed phase III clinical trial of the first drug designed to help children with this condition. Next step: the drug maker Emalex Biosciences plans to seek approval from
More news about: Cincinnati Children's Hospital Medical Center
May 26, 2026, 11:18 ET Mountain Province Diamonds Announces Mailing of Meeting Materials For Annual and Special Meeting of Shareholders, Seeks Approvals to Facilitate Potential Restructuring Transaction
"Manual"); (ii) approve an ordinary resolution (the "Facility Fee Resolution") approving a US$1,000,000 facility fee (the "Facility Fee"); (iii) approve an ordinary resolution (the "Delisting Resolution") approving the voluntary delisting of the Shares (the "Delisting") from the
More news about: Mountain Province Diamonds Inc.
May 26, 2026, 10:50 ET New analysis shows Tryngolza® (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia
an RNA-targeted medicine being evaluated for the treatment of severe hypertriglyceridemia. Olezarsen is designed to lower the body's production of apoC-III, a protein produced in the liver that regulates triglyceride metabolism in the blood. Olezarsen is approved in the U.S., European Union, and other
More news about: Swedish Orphan Biovitrum AB
May 26, 2026, 10:46 ET New analysis shows Tryngolza® (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia
an RNA-targeted medicine being evaluated for the treatment of severe hypertriglyceridemia. Olezarsen is designed to lower the body's production of apoC-III, a protein produced in the liver that regulates triglyceride metabolism in the blood. Olezarsen is approved in the U.S., European Union, and other
More news about: Swedish Orphan Biovitrum AB